We're planning big things at FierceMarkets HQ. Readers should look forward to expanded coverage not only in biomarkers, but across the board in all life sciences news markets we cover. I'll have more to share in this space in the next two weeks at FierceBiotech, FiercePharma and FierceMedicalDevices.
Thanks for being part of the FierceMarkets community. Questions, comments and advice are always welcome from readers, so if you have some please drop me e-mail, a tweet, or connect on LinkedIn. -- Arsalan Arif, Publisher